Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Seattle Genetics
 More »

  • Top 25 Biotech Companies of 2013
    ... shares * price $18.09) % Change: 70.2% Position on 2012 List: Not ranked #19. Seattle Genetics 2013 Market Cap: $4.390 billion (5/2: 121,265,608 shares * price $36.20) 2012 ...
    7-15-2013
  • Bayer, Seattle Genetics Launch Up to $520M ADC Collaboration
    Seattle Genetics awarded worldwide rights for its auristatin-based antibody-drug conjugate technology, with antibodies to several oncology targets, to Bayer HealthCare, in a ...
    6-25-2013
  • 10 Minute Charge Heterogeneity Analysis for Development and Quality...
    Stan Kwok, Ph.D., senior scientist, Seattle Genetics, will present an overview of biotherapeutic formulation development, analytical methods for formulation screening, and the ...
    6-19-2013
  • Merck, BMS Immunotherapy Data Whets Clinical Oncology Appetite...
    Oncology meeting, the drug giants were in good company-Peregrine Pharmaceuticals and Seattle Genetics were among the smaller biopharmas to report promising clinical data this week. ...
    6-3-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Roche (Ventana Medical Systems) and Seattle Genetics and Takeda Pharmaceutical (Millennium: The Takeda Oncology Company) Agreement announced April ...
    5-9-2013
  • BMS Partners Again with Ambrx, in Up-to-$112M-and-Up ADC Collaboration
    Ambrx and BMS are among companies looking to develop ADCs: The list includes Roche (Genentech)'s Kadcyla, approved in February for breast cancer indications, and Seattle Genetics' ...
    5-3-2013
  • OBT Joins Boehringer Ingelheim in Cancer Drug Collaboration
    with Seattle Genetics, Medarex (since acquired by Bristol-Myers Squibb), Amgen, Biosite (now Alere), and BioWa, as well as development alliances with Sanofi and Menarini. ...
    4-29-2013
  • GEN | Biolinks
    ... Foundation Ireland Science Industries Switzerland SCILOG Seahorse Bioscience Seattle Genetics Selexis Sheffield Bio-Science Shimadzu Siga Technologies Sigma-Aldrich Signature ...
  • Meeting the Bioassay Challenge
    ... and Mary Hu, Ph.D., director, bioassay development and process analytics, Seattle Genetics. "Two curves that are highly precise can often be shown to be different when ...
    3-15-2013
  • Top 20 Venture Capital Firms
    ... Frazier Healthcare Ventures Location(s): Seattle and Menlo Park, CA Fund size and status: ... Delenex Therapeutics, Good Start Genetics, Imagen Biotech, Itero ...
    12-17-2012
  • GEN Reports on Growing Interest in Antibody-Drug Conjugates
    it. Other companies in the GEN article include Ambryx Biotechnology, Spirogen, ADC Therapeutics, Mersana Therapeutics, Seattle Genetics, Roche/Genentech, ImmunoGen, and Pfizer.
    12-10-2012
  • Cancer Research Firms Eye ADCs to Extend Portfolios
    ... Spirogen "Spirogen has developed its own novel, very potent payload and a novel mechanism of action. It's one to watch," Chew says. "Genentech and Seattle Genetics are each ...
    12-1-2012
  • EC Conditionally Sanctions Lymphoma Treatment
    The EC granted conditional approval for Seattle Genetics and Millennium's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) for two indications: the treatment of adult ...
    10-31-2012
  • Abbott and Seattle Expand ADC Collaboration
    Abbott is paying Seattle Genetics $25 million to expand the firms' existing antibody-drug conjugate (ADC) alliance. The new deal gives Abbott access to Seattle's auristatin-based ...
    10-23-2012
  • Top 25 Biotech Companies
    using share prices as of June 29, since markets were closed on June 30. #25. Seattle Genetics 2012 Market Cap: $2.92 billion (8/2: 118,207,214 shares at price $24.72) 2011 ...
    8-17-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll